Novel Discovery by NUS Scientists Improves Profiling of Aml Patients for Targeted Therapies

Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have identified a set of genes, including DNMT3A, that could potentially be used to predict clinical outcomes of patients who suffer from a type of Acute Myeloid Leukemia associated with an FLT3 internal tandem duplication mutation.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews